These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16253559

  • 21. Prospects for a novel vaccine against tuberculosis.
    Dietrich J, Weldingh K, Andersen P.
    Vet Microbiol; 2006 Feb 25; 112(2-4):163-9. PubMed ID: 16325357
    [Abstract] [Full Text] [Related]

  • 22. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P.
    Eur J Immunol; 2006 Dec 25; 36(12):3346-55. PubMed ID: 17109467
    [Abstract] [Full Text] [Related]

  • 23. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 25; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 24. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB, Kalra M, Verma I, Khuller GK.
    Clin Immunol; 2007 Mar 25; 122(3):239-51. PubMed ID: 17208519
    [Abstract] [Full Text] [Related]

  • 25. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
    Li H, Li R, Zhong S, Ren H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 25; 23(4):291-4. PubMed ID: 17428378
    [Abstract] [Full Text] [Related]

  • 26. A review of vaccine research and development: tuberculosis.
    Girard MP, Fruth U, Kieny MP.
    Vaccine; 2005 Dec 30; 23(50):5725-31. PubMed ID: 16153751
    [Abstract] [Full Text] [Related]

  • 27. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA, Hernández-Pando R, Zumla A.
    J Infect Dis; 2009 Mar 01; 199(5):613-8. PubMed ID: 19199549
    [Abstract] [Full Text] [Related]

  • 28. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope.
    Shi C, Zhang H, Zhang T, Wang X, Bai B, Zhao Y, Zhang C, Xu Z.
    Scand J Immunol; 2009 Nov 01; 70(5):465-74. PubMed ID: 19874551
    [Abstract] [Full Text] [Related]

  • 29. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
    Sambandamurthy VK, Derrick SC, Hsu T, Chen B, Larsen MH, Jalapathy KV, Chen M, Kim J, Porcelli SA, Chan J, Morris SL, Jacobs WR.
    Vaccine; 2006 Sep 11; 24(37-39):6309-20. PubMed ID: 16860907
    [Abstract] [Full Text] [Related]

  • 30. Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis.
    Goldsack L, Kirman JR.
    Tuberculosis (Edinb); 2007 Nov 11; 87(6):465-73. PubMed ID: 17719276
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tuberculosis vaccine development: strength lies in tenacity.
    Kaufmann SH.
    Trends Immunol; 2012 Jul 11; 33(7):373-9. PubMed ID: 22560865
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vaccines for TB: Lessons from the Past Translating into Future Potentials.
    Tye GJ, Lew MH, Choong YS, Lim TS, Sarmiento ME, Acosta A, Norazmi MN.
    J Immunol Res; 2015 Jul 11; 2015():916780. PubMed ID: 26146643
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA, Dockrell HM.
    Future Microbiol; 2016 Jun 11; 11():781-7. PubMed ID: 27203133
    [Abstract] [Full Text] [Related]

  • 37. Childhood tuberculosis: old and new vaccines.
    Hussey G, Hawkridge T, Hanekom W.
    Paediatr Respir Rev; 2007 Jun 11; 8(2):148-54. PubMed ID: 17574159
    [Abstract] [Full Text] [Related]

  • 38. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK, Khuller GK.
    Expert Rev Vaccines; 2008 Nov 11; 7(9):1341-56. PubMed ID: 18980538
    [Abstract] [Full Text] [Related]

  • 39. Systems approach to tuberculosis vaccine development.
    Wang CC, Zhu B, Fan X, Gicquel B, Zhang Y.
    Respirology; 2013 Apr 11; 18(3):412-20. PubMed ID: 23331331
    [Abstract] [Full Text] [Related]

  • 40. Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccination.
    Orme IM.
    Tuberculosis (Edinb); 2006 Jan 11; 86(1):68-73. PubMed ID: 16260181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.